MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Homozygous BZRAP1 mutations cause autosomal recessive dystonia

NE. Mencacci, MM. Brockmann, S. Pajusalu, B. Atasu, P. Gonzalez-Latapi, M. Schwake, B. Balint, A. Papandreou, A. Pittman, J. Simon-Sanchez, S. Wiethoff, TT. Warner, T. Gasser, M. Kurian, E. Lohmann, K. õunap, KP. Bhatia, C. Rosenmund, T. Sudhof, NW. Wood, D. Krainc, C. Acuna Goycolea (Chicago, IL, USA)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Homozygous Huntington’s disease with two reduced penetrance alleles: A Case Report

K. Grimm, C. Zühlke, C. Gerloff, S. Zittel (Hamburg, Germany)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Huntington Disease-Like 2: A Case Presentation and Review of the Literature

J. Pleen, V. Saini, N. Doher, R. Walker, V. Singh (Kansas City, KS, USA)

Choreas (Non-Huntington’s Disease)  ·  Les Muses, Level 3
1:45pm-3:15pm
Huntington’s Disease Protein Huntingtin Associates with its own mRNA

M. Rakhimova, M. Daropova (Tashkent, Uzbekistan)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Huntington’s Disease presenting as sporadic cerebellar ataxia

GLF. Franklin, FAN. Nascimento, GMP. Pavanelli, SSM. Milano, HAT. Teive, NSL. Lima, SR. Raskin (Curitiba, Brazil)

Ataxia  ·  Les Muses, Level 3
1:45pm-3:15pm
Huntington’s disease: A case review of Sub-Saharan Africans with diverse origins

M. Muthinja, J. Hooker (Nairobi, Kenya)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Hydralazine protects nigrostriatal dopaminergic neurons from MPP+ and MPTP induced neurotoxicity: Roles of Nrf2-ARE signaling pathway

XF. Guo, T. Wang, J. Huang, N. Xiong, C. Han, K. Ma, Y. Xia, F. Wan, JJ. Hu, SJ. Yin, L. Kou, YD. Sun, JW. Wu (Wuhan, China)

Neuropharmacology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Hyperammonemic Encephalopathy as Primary Cause of Movement Disorders: Report of Two Cases

G. Fabiani, FMB. Germiniani, S. Raskin, HAG. Teive (Curitiba, Brazil)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Hyperkinetic Movement Disorders in Congenital Disorders of Glycosylation

G. Mostile, R. Barone, A. Nicoletti, R. Rizzo, D. Martinelli, L. Sturiale, A. Fiumara, J. Jankovic, M. Zappia (Catania, Italy)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Hypophosphatasia presenting as parkinsonism with compound heterozygous mutations in ALPL gene

WF. Yu, ZX. Zhao, LW. Liu, JL. Hu, FF. Wang, YM. Liu (Jinan, China)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley